This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Textor, S. C. Articles by Tarazi, R. C. Search for Related Content PubMed PubMed Citation Articles by Textor, S. C. Articles by Tarazi, R. C.

Hypertension, Vol 5, 796-804, Copyright © 1983 by American Heart Association

ARTICLES

Responses of the stenosed and contralateral kidneys to [Sar1, Thr8] AII in human renovascular hypertension

SC Textor, A Novick, SK Mujais, R Ross, EL Bravo, FM Fouad and RC Tarazi

To better define the intrarenal hemodynamic effects of angiotensin in human renovascular hypertension, 10 patients underwent renal hemodynamic and functional measurements before and during infusion of a competitive angiotensin analog, [Sar1, Thr8] AII. Eight had technically satisfactory split function studies. Despite a fall in mean arterial pressure (132 +/- 6 to 121 +/- 6 mm Hg, p less than 0.05) and humoral changes consistent with angiotensin-mediated hypertension, the intrarenal effects of this analog were commonly those of an angiotensin agonist, producing vasoconstriction and sodium retention. This was quantitatively greatest in the contralateral kidney, whose preinfusion sodium excretion (86 +/- 30 microEq/min vs 25 +/- 9 microEq/min, p less than 0.02) and glomerular filtration rate (76 +/- 7 ml/min vs 41 +/- 7 ml/min, p less than 0.01) were higher than the stenotic kidney. In some cases, an increase in renal blood flow and rise in sodium excretion were evident during angiotensin blockade, suggesting a tonic intrarenal action of angiotensin. Although renin vein renin values differed markedly between the stenotic and contralateral kidney (ratio = 2.05 +/- 0.30), relative changes in effective renal plasma flow were correlated (r = 0.84: p less than 0.01) during infusion of this analog. These results underscore the differences in sensitivities between vascular beds to the effects of angiotensin II and the major role of the contralateral kidney in renal function and sodium homeostasis in human renovascular hypertension.

This article has been cited by other articles:

				V. D. Garovic and S. C. Textor Renovascular Hypertension and Ischemic Nephropathy Circulation, August 30, 2005; 112(9): 1362 - 1374. [Full Text] [PDF]

				M. Rodriguez-Porcel, J. D. Krier, A. Lerman, P. F. Sheedy II, J. C. Romero, C. Napoli, and L. O. Lerman Combination of Hypercholesterolemia and Hypertension Augments Renal Function Abnormalities Hypertension, February 1, 2001; 37(2): 774 - 780. [Abstract] [Full Text] [PDF]

				L. O. LERMAN, R. S. SCHWARTZ, J. P. GRANDE, P. F. SHEEDY II, and J. C. ROMERO Noninvasive Evaluation of a Novel Swine Model of Renal Artery Stenosis J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1455 - 1465. [Abstract] [Full Text]

				H. Kumagai, H. Suzuki, S. Matsukawa, M. Ryuzaki, and T. Saruta Captopril Therapy Following Percutaneous Transluminal Angioplasty for Bilateral Renal Artery Stenosis Arch Intern Med, September 1, 1989; 149(9): 1973 - 1976. [Abstract] [PDF]